These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 20824812
1. DMBT1 is a novel gene induced by IL-22 in ulcerative colitis. Fukui H, Sekikawa A, Tanaka H, Fujimori Y, Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T, Fujimori T. Inflamm Bowel Dis; 2011 May; 17(5):1177-88. PubMed ID: 20824812 [Abstract] [Full Text] [Related]
2. Involvement of the IL-22/REG Ialpha axis in ulcerative colitis. Sekikawa A, Fukui H, Suzuki K, Karibe T, Fujii S, Ichikawa K, Tomita S, Imura J, Shiratori K, Chiba T, Fujimori T. Lab Invest; 2010 Mar; 90(3):496-505. PubMed ID: 20065946 [Abstract] [Full Text] [Related]
3. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH. Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374 [Abstract] [Full Text] [Related]
4. Expression of Interleukin-26 is upregulated in inflammatory bowel disease. Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A. World J Gastroenterol; 2017 Aug 14; 23(30):5519-5529. PubMed ID: 28852311 [Abstract] [Full Text] [Related]
5. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. Gan HT, Chen YQ, Ouyang Q. J Gastroenterol Hepatol; 2005 Jul 14; 20(7):1016-24. PubMed ID: 15955209 [Abstract] [Full Text] [Related]
6. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. World J Gastroenterol; 2013 May 07; 19(17):2638-49. PubMed ID: 23674871 [Abstract] [Full Text] [Related]
8. Epithelial expression of interleukin-37b in inflammatory bowel disease. Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y, Andoh A. Clin Exp Immunol; 2013 Jun 07; 172(3):410-6. PubMed ID: 23600829 [Abstract] [Full Text] [Related]
9. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. Ren TH, Lv MM, An XM, Leung WK, Seto WK. J Dig Dis; 2020 Jan 07; 21(1):38-45. PubMed ID: 31714673 [Abstract] [Full Text] [Related]
10. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y. Gastroenterology; 2005 Sep 07; 129(3):969-84. PubMed ID: 16143135 [Abstract] [Full Text] [Related]
11. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Polytarchou C, Hommes DW, Palumbo T, Hatziapostolou M, Koutsioumpa M, Koukos G, van der Meulen-de Jong AE, Oikonomopoulos A, van Deen WK, Vorvis C, Serebrennikova OB, Birli E, Choi J, Chang L, Anton PA, Tsichlis PN, Pothoulakis C, Verspaget HW, Iliopoulos D. Gastroenterology; 2015 Oct 07; 149(4):981-92.e11. PubMed ID: 26055138 [Abstract] [Full Text] [Related]
14. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. Awane M, Andres PG, Li DJ, Reinecker HC. J Immunol; 1999 May 01; 162(9):5337-44. PubMed ID: 10228009 [Abstract] [Full Text] [Related]
15. IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. Fonseca-Camarillo G, Furuzawa-Carballeda J, Llorente L, Yamamoto-Furusho JK. J Clin Immunol; 2013 Apr 01; 33(3):640-8. PubMed ID: 23207823 [Abstract] [Full Text] [Related]
16. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Fölsch UR, Helmke B, Autschbach F, Schirmacher P, Kioschis P, Hafner M, Poustka A, Mollenhauer J, Schreiber S. J Immunol; 2007 Jun 15; 178(12):8203-11. PubMed ID: 17548659 [Abstract] [Full Text] [Related]
17. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. Diegelmann J, Olszak T, Göke B, Blumberg RS, Brand S. J Biol Chem; 2012 Jan 02; 287(1):286-298. PubMed ID: 22069308 [Abstract] [Full Text] [Related]
18. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S. Gut; 2009 Sep 02; 58(9):1207-17. PubMed ID: 18483078 [Abstract] [Full Text] [Related]
19. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Pedersen G, Andresen L, Matthiessen MW, Rask-Madsen J, Brynskov J. Clin Exp Immunol; 2005 Aug 02; 141(2):298-306. PubMed ID: 15996194 [Abstract] [Full Text] [Related]
20. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. Valmiki S, Ahuja V, Paul J. World J Gastroenterol; 2017 Aug 07; 23(29):5324-5332. PubMed ID: 28839432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]